Exponent (NASDAQ:EXPO) Issues Earnings Results

Exponent (NASDAQ:EXPO) announced its quarterly earnings results on Thursday. The business services provider reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.60 by $0.04, FiscalAI reports. The company had revenue of $173.73 million during the quarter, compared to the consensus estimate of $149.64 million. Exponent had a net margin of 17.67% and a return on equity of 31.48%.

Exponent Trading Up 1.6%

NASDAQ:EXPO traded up $1.20 during midday trading on Thursday, hitting $78.31. 874,111 shares of the stock were exchanged, compared to its average volume of 516,754. The company has a market capitalization of $3.72 billion, a price-to-earnings ratio of 35.12 and a beta of 0.69. Exponent has a one year low of $51.91 and a one year high of $81.95. The business has a 50-day moving average price of $69.81 and a two-hundred day moving average price of $66.59.

Analyst Ratings Changes

A number of research firms have issued reports on EXPO. Weiss Ratings raised shares of Exponent from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. UBS Group set a $72.00 price target on shares of Exponent and gave the company a “neutral” rating in a research note on Friday, July 31st. Finally, JPMorgan Chase & Co. lifted their price target on Exponent from $80.00 to $90.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.00.

Insiders Place Their Bets

In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $66.28, for a total value of $113,139.96. Following the sale, the chief executive officer directly owned 129,108 shares in the company, valued at approximately $8,557,278.24. The trade was a 1.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by corporate insiders.

Exponent Company Profile

Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.